Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 known ✓ | O43570 | 2/20 | 0.38 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.38 |
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.36 |
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | DUSP5 | Q16690 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
| ▸ | DUSP6 | Q16828 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MPO | P05164 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL1538011 | 0.92 | LMNA (0.48) | LMNATDP1DUSP5PTPN1DUSP6 | |
| SCHEMBL28934944 | 0.92 | LMNA (0.48) | LMNATDP1DUSP5PTPN1DUSP6 | |
| SCHEMBL5846996 | 0.90 | CA12 (0.52) | LMNATDP1DUSP5PTPN1DUSP6 | |
| SCHEMBL3171668 | 0.90 | CA12 (0.52) | LMNATDP1DUSP5PTPN1DUSP6 | |
| SCHEMBL28477667 | 0.87 | HTR6 (0.55) | LMNATDP1TSHRALDH1A1CA12 | |
| SCHEMBL3409456 | 0.87 | HTR6 (0.55) | LMNATDP1TSHRALDH1A1CA12 | |
| SCHEMBL28929 | 0.87 | HTR6 (0.55) | LMNATDP1TSHRALDH1A1CA12 | |
| SCHEMBL1981609 | 0.87 | HTR6 (0.55) | LMNATDP1TSHRALDH1A1CA12 | |
| SCHEMBL6740023 | 0.87 | HTR6 (0.55) | LMNATDP1TSHRALDH1A1CA12 | |
| SCHEMBL11761400 | 0.87 | HTR6 (0.55) | LMNATDP1TSHRALDH1A1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4302082-B1 | ASSEMBLY COMPRISING A WINDOW PANE WITH AT LEAST ONE CAPACITIVE HUMIDITY SENSOR AND ELECTRONIC PROCESSING MEANS | SAINT GOBAIN SEKURIT FRANCE (FR) | 2026-04-15 | — | — | EP | claimed |
| US-20250270168-A1 | SYNTHESIS PROCESS FOR HIGH PURITY ISOSULFAN BLUE USING FLASH CHROMATOGRAPHY IN COMMERCIAL PLANT SCALE | RISING PHARMA HOLDINGS, INC. (US) | 2025-08-28 | — | — | US | claimed |
| US-12180142-B1 | Synthesis process for high purity isosulfan blue using flash chromatography in commercial plant scale | RISING PHARMA HOLDINGS, INC. (US) | 2024-12-31 | — | — | US | claimed |
| EP-4302082-A1 | GLAZING PROVIDED WITH A CAPACITIVE HUMIDITY SENSOR | Saint-Gobain Glass France (FR) | 2024-01-10 | — | — | EP | claimed |
| WO-2022184988-A1 | GLAZING PROVIDED WITH A CAPACITIVE HUMIDITY SENSOR | SAINT-GOBAIN GLASS FRANCE (FR) | 2022-09-09 | — | — | WO | claimed |
| WO-2018046930-A1 | PROCESS FOR THE PREPARATION OF ZIRCONIUM BASED MOFS. | UNIVERSITETET I OSLO (NO) | 2018-03-15 | — | — | WO | claimed |
| US-20250270168-A1 | SYNTHESIS PROCESS FOR HIGH PURITY ISOSULFAN BLUE USING FLASH CHROMATOGRAPHY IN COMMERCIAL PLANT SCALE | RISING PHARMA HOLDINGS, INC. (US) | 2025-08-28 | — | — | US | disclosed |
| US-12180142-B1 | Synthesis process for high purity isosulfan blue using flash chromatography in commercial plant scale | RISING PHARMA HOLDINGS, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| CN-118851949-A | Synthesis method of triarylmethane sulfone compound | 普如制药生命解决方案公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-115551830-B | Synthesis method of triarylmethane sulfone compound | 普如制药生命解决方案公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-115485264-B | Synthesis method of triarylmethane sulfone compound | 普如制药生命解决方案公司 | 2024-07-19 | — | — | CN | disclosed |
| EP-4302082-A1 | GLAZING PROVIDED WITH A CAPACITIVE HUMIDITY SENSOR | Saint-Gobain Glass France (FR) | 2024-01-10 | — | — | EP | disclosed |
| CN-115551830-A | Synthesis method of triarylmethane sulfone compound | 普如制药生命解决方案公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-115485264-A | Method for synthesizing triarylmethane sulfone compound | 普如制药生命解决方案公司 | 2022-12-16 | — | — | CN | disclosed |
| WO-2022184988-A1 | GLAZING PROVIDED WITH A CAPACITIVE HUMIDITY SENSOR | SAINT-GOBAIN GLASS FRANCE (FR) | 2022-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270168-A1 | SYNTHESIS PROCESS FOR HIGH PURITY ISOSULFAN BLUE USING FLASH CHROMATOGRAPHY IN COMMERCIAL PLANT SCALE | CBS, SLC6A12, RPS4Y1 | CA12 801/4885CA2 185/4885CA1 2130/4885 |
| US-12180142-B1 | Synthesis process for high purity isosulfan blue using flash chromatography in commercial plant scale | CBS, SLC6A12, RPS4Y1 | CA12 801/4885CA2 185/4885CA1 2130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.